Brochures

Test Brochures / Case Studies

Heme Brochure 8.5x11 v.2.6 web
Hematology Brochure
Solid Tumor Brochure 8.5x11 v.2.6 web
Solid Tumor Brochure
GTC's Liquid Trace Brochure v.5.0
Liquid Trace Brochure
Pharma n Research Services Brochure v.2.0 web
Research and Pharma Services Brochure
Physicians Brochure v.3.14 web
Physicians Brochure
Prostate Cancer Case Study Brochure 8.5x11 v.1.2 web
Prostate Cancer Case Study Brochure
cfDNA Case Study Brochure
cfDNA Case Study Brochure
VEXAS Case Study Brochure
VEXAS Case Study Brochure
CUP Case Study Brochure
CUP Case Study Brochure
ESR1 Case Study Brochure 8.5x11
ESR1 Case Study Brochure
Case study Detection of Multiple Myeloma - Cover
Multiple Myeloma Case Study Brochure
CHIP - CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL -Brochure_2023
CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Cutaneous Lymphoid Lesions
Cutaneous Lymphoid Lesions Brochure
A better way to evaluate and classify most patients with Lymphoma
Lymphoma Brochure
A better way to evaluate patients for Leukemia
Leukemia Brochure
Multiple Myeloma Brochure
Multiple Myeloma Brochure
CSF Brochure
CSF Brochure
Interprestation™ Brochure
Lung Cancer Brochure
Breast Cancer Brochure
Sarcoma Brochure

Published Posters

ASH 2024

Establishing a Distinct Cytokine Signature for Multiple Myeloma
Using Bone Marrow RNA and Peripheral Blood Cell-Free RNA (cfRNA)

Establishing Distinct Cytokine Signatures Differentiating between Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Chip Using Bone Marrow RNA or Cell-Free RNA (cfRNA)

Establishing Lymphoma Type-Specific Cytokine Signatures
Using Tissue-Based RNA or Peripheral Blood Cell-Free RNA (cfRNA)

Clonotype- naive Detection Of Clonality in Patients Suspected of Having Multiple Myeloma or Monoclonal Gammopathy Using Peripheral Blood Cell-Free RNA (cfRNA)

ASCO 2024

Poster 1033

Multiple Alternative Splicing of HER2 transcripts
and Exon Skipping with Potential Consequences on Function and Antibody-Based Therapy

Poster 3048

Using Cell-Free RNA in Monitoring Immune System and the Demonstration of Significant Systemic Deficiency in Lymphoid and Myeloid Biomarkers in Patients with Cancer

ASCO 2023

2023-ASCO poster - 3043


Distinguishing between cancer-related mutations and clonal hematopoiesis using cell-free RNA (cfRNA) expression levels in a machine learning model

2023-ASCO poster - 7060


Defining the immune microenvironment
in myelodysplastic syndrome
and acute myeloid leukemia
using machine learning

2023-ASCO Machine Learning poster - 2634

Using machine learning to characterize lung cancer microenvironment and the development of a model to predict the presence of similar microenvironment in other cancers

ASH 2023

USING NEXT GENERATION SEQUENCING OF FLOW CYTOMETRY CD MARKERS AND MACHINE LEARNING AS A REPLACEMENT TO FLOW CYTOMETRY ANALYSIS FOR THE DIAGNOSIS OF HEMATOLOGIC NEOPLASMS

USING NEXT GENERATION SEQUENCING OF FLOW CYTOMETRY CD MARKERS AND MACHINE LEARNING AS A REPLACEMENT TO FLOW CYTOMETRY ANALYSIS FOR THE DIAGNOSIS OF HEMATOLOGIC NEOPLASMS

LYMPHOMA DIAGNOSIS AND CLASSIFICATION USING NEXT GENERATION SEQUENCING OF 30 CD MARKERS AND MACHINE LEARNING AS AN ALTERNATIVE TO IMMUNOHISTOCHEMISTRY


LYMPHOMA DIAGNOSIS AND CLASSIFICATION USING NEXT GENERATION SEQUENCING OF 30 CD MARKERS AND MACHINE LEARNING AS AN ALTERNATIVE TO IMMUNOHISTOCHEMISTRY

AACR 2023

Predicting PD-L1 status in solid tumors using transcriptomic data and artificial intelligence algorithms

Predicting PD-L1 Status in Solid Tumors Using Transcriptomic Data and Artificial Intelligence Algorithms

The molecular landscape of premenopausal versus postmenopausal breast cancer in patients without inherited predisposition mutations

The Molecular Landscape of Premenopausal Versus Postmenopausal Breast Cancer in Patients Without Inherited Predisposition Mutations

Real-world transcriptomic biomarkers as replacement for immunohistochemistry and FISH studies in breast cancer

ASCO 2022

Combining cell-free RNA (cfRNA) with cell-free total nucleic acid (cfTNA) as a new paradigm for liquid biopsy

Cell-free RNA in liquid biopsy and biomarkers profiling of hematologic and solid tumors

Differential diagnosis of hematologic and solid tumors using targeted transcriptome and artificial intelligence

ASH 2022

DNA AND RNA PROFILES IN MACHINE LEARNING ALGORITHM TO PREDICT WHICH PATIENTS WITH AML/MDS WILL RESPOND TO VENETOCLAX-BASED THERAPY

LIQUID IMMUNOPHENOTYPING
AND THE DIAGNOSIS OF LYMPHOID NEOPLASMS
USING CELL-FREE RNA

ASH 2021

Bone Marrow-Based Biomarkers for Predicting aGVHD Using Targeted RNA Next Generation Sequencing and Machine Learning

Reliability of Liquid Biopsy and Next Generation Sequencing in Monitoring Residual Disease Post-Hematopoietic Stem Cell Transplant

Determining Clinical Course of Diffuse Large B-cell lymphoma
Using Targeted Transcriptome
and Machine Learning Algorithms

Reliability of Cell-Free DNA (cfDNA) Next Generation Sequencing in Predicting Chromosomal Structural Abnormalities and Cytogenetic-Risk Stratification of Patients with Myeloid Neoplasms.